Novo Will Seek Tresiba Anti-Hypoglycemia Claim In 2016, Firm Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm is aiming to make Tresiba the first basal insulin to carry a claim for reduced risk of hypoglycemia.